Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2004 Apr-May;1(1):9-13.
doi: 10.1007/s11897-004-0011-x.

Pharmacologic effects on cardiac remodeling

Affiliations
Review

Pharmacologic effects on cardiac remodeling

Norman Sharpe. Curr Heart Fail Rep. 2004 Apr-May.

Abstract

Clinical research during the past several decades has shown the importance of cardiac remodeling as a basic mechanism in the progression of heart failure. Changes in cardiac remodeling have high concordance with long-term clinical outcomes. Cardiac remodeling should be regarded as a primary target for treatment and also can serve as a reliable surrogate for clinical outcomes. Neurohormonal blockade with combination treatments that inhibit the renin-angiotensin-aldosterone and sympathetic systems has proven effective in improving cardiac remodeling and clinical outcomes. Such treatment should be standard therapy for patients with left ventricular dysfunction after myocardial infarction and patients with chronic heart failure.

PubMed Disclaimer

References

    1. Circulation. 2000 Nov 28;102(22):2700-6 - PubMed
    1. Circulation. 1992 Aug;86(2):431-8 - PubMed
    1. J Am Coll Cardiol. 1986 Feb;7(2):349-54 - PubMed
    1. N Engl J Med. 1988 Jul 14;319(2):80-6 - PubMed
    1. Circulation. 1994 Jan;89(1):61-7 - PubMed

MeSH terms

Substances

LinkOut - more resources